Gamow Labs, Inc.
PrivateLast Round
Seed Round
Jun 11, 2026
Total Funding Raised
$3.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Gamow Labs, Inc. operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in June 2026.
Gamow Labs, Inc. is a biotechnology and artificial intelligence company that develops an AI-native genomic interpretation platform for clinical medicine.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Medical AI, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gamow Labs, Inc. Comparables
Compare Gamow Labs, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Breakthrough Genomics | 84% | |
| enGenome | 79% | |
| GeneDx Holdings Corp. | 76% |
For institutional investors. Book with your work email.
Gamow Labs, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 11, 2026 | ||||
| Seed | Jun 11, 2026 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2026
Grew 100% QoQ from 3 to 6 employees.
- Jun 11, 2026
$4M raised in seed funding.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesNov 4, 2026
Gamow Labs develops a high-throughput RNA-sequencing platform that measures how genetic or chemical perturbations affect cell state.
- adopts_technologyOct 14, 2026
Gamow Labs uses Argon in life sciences to identify a chromosomal rearrangement in a newborn with a rare lung disorder that standard software misses for years.
- partners_withOct 13, 2026
Gamow Labs partners with Baylor College of Medicine in a research study that uses an AI tool to reanalyze a genome and uncover a hidden genetic clue that clinicians confirm for a diagnosis.
- is_developingAug 17, 2026
Gamow Labs is developing AI systems to make state-of-the-art neonatal genomic care more accessible and improve rare disease diagnostic rates as of Aug 17th '26.
For institutional investors. Book with your work email.
Gamow Labs, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gamow Labs, Inc.'s valuation, stock price, and market status.
Is Gamow Labs, Inc. a public or private company?
Gamow Labs, Inc. is a private company.
What is the current stock price of Gamow Labs, Inc.?
Gamow Labs, Inc. is a private company, so its shares have no public market price. Caplight tracks Gamow Labs, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gamow Labs, Inc. worth (valuation)?
Valuation information for Gamow Labs, Inc. is not publicly available.
Can I buy Gamow Labs, Inc. stock?
Gamow Labs, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gamow Labs, Inc.'s last funding round?
Gamow Labs, Inc.'s most recent funding round was Seed Round on June 11, 2026.
Who are the main investors in Gamow Labs, Inc.?
Investor information for Gamow Labs, Inc. is not publicly disclosed.
Will Gamow Labs, Inc. IPO soon?
No public IPO plans have been announced for Gamow Labs, Inc..
How can I track Gamow Labs, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Gamow Labs, Inc.'s shares on secondary markets.